$6.99 -0.42 (%) Anthera Pharmaceuticals Inc - NASDAQ

Sep. 3, 2015 | 01:05 PM

Partner Headlines

  1. Mid-Morning Market Update: Markets Mostly Flat; Morgan Stanley Beats Q2 Views

    Benzinga | Jul. 20, 2015 | 10:18AM EST
  2. Mid-Afternoon Market Update: Micron Gains On Rumor Of Tsinghua Bid; Navient Shares Drop

    Benzinga | Jul. 14, 2015 | 15:14PM EST
  3. Anthera Pharmaceuticals Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares, Can Purchase 500K Additional Shares to 3.833M Offered at $7.50/Share

    Benzinga | Jul. 14, 2015 | 12:06PM EST
  4. Mid-Day Market Update: Walgreens Surges On Earnings Beat; Coty Shares Slide

    Benzinga | Jul. 9, 2015 | 13:18PM EST
  5. Mid-Morning Market Update: Markets Open Higher; PepsiCo Earnings Beat Views

    Benzinga | Jul. 9, 2015 | 12:16PM EST
  6. Morning Market Losers

    Benzinga | Jul. 9, 2015 | 09:58AM EST
  7. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 9, 2015 | 08:19AM EST
  8. 7 Stocks To Watch For July 9, 2015

    Benzinga | Jul. 9, 2015 | 04:54AM EST
  9. Why Alcoa, WD-40, Alibaba, Herbalife, Anthera Pharma Are Moving After-Hours

    Benzinga | Jul. 8, 2015 | 16:55PM EST
  10. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

    Benzinga | Jul. 8, 2015 | 16:04PM EST
  11. Universal Health Services CEO: ObamaCare Ruling No Surprise

    FoxBusiness | Jun. 25, 2015 | 18:49PM EST
  12. Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates

    Benzinga | Jun. 24, 2015 | 10:20AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 13, 2015 | 08:13AM EST
  14. Morning Market Gainers

    Benzinga | May. 12, 2015 | 09:41AM EST
  15. Benzinga's Top Upgrades

    Benzinga | May. 12, 2015 | 09:28AM EST
  16. Citigroup Upgrades Anthera Pharmaceuticals To Neutral

    Benzinga | May. 12, 2015 | 08:56AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 12, 2015 | 08:15AM EST
  18. Morning Market Gainers

    Benzinga | Feb. 10, 2015 | 09:49AM EST
  19. Anthera Pharmaceuticals Announces Update On Strategic Partnership Discussions for Blisibimod

    Benzinga | Oct. 1, 2014 | 16:00PM EST
  20. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 17, 2014 | 10:07AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 15, 2014 | 08:14AM EST
  22. Anthera Pharmaceuticals Announces Acquisition of Sollpura For Exocrine Pancreatic Insufficiency From Eli Lilly And Company - No Terms

    Benzinga | Jul. 14, 2014 | 16:43PM EST
  23. Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company

    Benzinga | Feb. 10, 2014 | 16:16PM EST
  24. Anthera Pharmaceuticals Accused of Withholding Data

    Benzinga | Nov. 20, 2013 | 15:16PM EST
  25. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 11:36AM EST
  26. Benzinga's Microcap Movers for Monday September 17, 2012

    Benzinga | Sep. 17, 2012 | 16:29PM EST
  27. Benzinga's Microcap Movers for Friday August 24, 2012

    Benzinga | Aug. 26, 2012 | 03:27AM EST
  28. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 06:33AM EST
  29. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock; 33M Shares at $1.00/Share

    Benzinga | Jul. 19, 2012 | 03:16AM EST
  30. Benzinga's Microcap Movers for Wednesday July 18, 2012

    Benzinga | Jul. 18, 2012 | 16:00PM EST
  31. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock; No Amount Given

    Benzinga | Jul. 18, 2012 | 10:23AM EST
  32. Benzinga's Microcap Movers for Tuesday July 17, 2012

    Benzinga | Jul. 17, 2012 | 10:57AM EST
  33. Benzinga's Microcap Movers for Monday July 16, 2012

    Benzinga | Jul. 16, 2012 | 10:38AM EST
  34. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population

    Benzinga | Jul. 16, 2012 | 02:45AM EST
  35. Anthera Pharmaceuticals Inc. (ANTH) CEO Paul F Truex buys 20,000 Shares

    GuruFocus | Jul. 2, 2012 | 12:19PM EST
  36. ProShares Trust Ultra VIX Short Term Futures ETF, Nokia Corporation Among Stocks setting 52-Week Lows Friday

    FoxBusiness | Jun. 29, 2012 | 06:32AM EST
  37. Health Care Sector Wrap

    FoxBusiness | Jun. 28, 2012 | 10:47AM EST
  38. Anthera Pharmaceuticals Down 65% After Reporting Phase 2b PEARL-SC Clinical Study Results

    Benzinga | Jun. 28, 2012 | 04:55AM EST
  39. Benzinga's Top Downgrades

    Benzinga | Jun. 28, 2012 | 01:40AM EST
  40. Anthera Updates Phase 3 Plans

    Benzinga | Jun. 27, 2012 | 11:57AM EST
  41. Benzinga's Microcap Movers for Friday June 15, 2012

    Benzinga | Jun. 16, 2012 | 04:01AM EST
  42. Stock Futures Little Changed Ahead of Data with Morgan Stanley (MS) and Google (GOOG) on the Move

    MarketIntelligenceCenter | Mar. 16, 2012 | 08:03AM EST
  43. UPDATE: Summer Street Research Partners Initiates Buy, $15 PT on Anthera Pharmaceuticals

    Benzinga | Mar. 2, 2012 | 06:19AM EST
  44. Morning Social Media Outlook for Wednesday Feb 22

    Benzinga | Feb. 22, 2012 | 04:05AM EST
  45. Anthera Pharmaceuticals Inc. (ANTH) President and CEO Paul F Truex sells 15,000 Shares

    GuruFocus | Dec. 16, 2011 | 15:31PM EST
  46. Anthera Announces Completion of Safety Review by DSMB for VISTA-16

    Benzinga | Dec. 14, 2011 | 10:00AM EST
  47. UPDATE: Canaccord Initiates Buy, $13 Target on Anthera Pharmaceuticals

    Benzinga | Dec. 8, 2011 | 02:37AM EST
  48. Canaccord Initiates Anthera Pharmaceuticals at Buy, $13 PT

    Benzinga | Dec. 8, 2011 | 01:17AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!